The Schwank Lab is located at the Institute of Pharmacology and Toxicology at the University of Zurich. Our main goal is the clinical translation of genome editing tools. We engineer novel CRISPR-based genome editing variants, develop vehicles and approaches for their in vivo delivery, and conduct CRISPR screens to unravel the genetic components of complex diseases such as cancer. Learn more about our research here.